C. Albera (Orbassano/Torino, Italy), K. Antoniou (Heraklion, Greece)
Cryptogenic organising pneumonia – clarithromycin treatment – factors influencing treatment results and relapses
E. Radzikowska, E. Wiatr, R. Langfort, I. Bestry, M. Plodziszewska, K. Roszkowski (Warsaw, Poland)
|  |
Amiodarone: an audit to assess monitoring practices
L. D. Toms, M. M. Wordsworth, C. I. Bloom, B. Mann (London, United Kingdom)
| |
Acute life threatening lipoid-pneumonia after accidentally intravenous injection of an anabolic
F. Quadri, M. Previsdomini, S. Györik (Bellinzona, Switzerland)
|  |
Nasal carriage of Staphylococcus aureus and relapse rate in intestinal lung disease due to Wegener‘s granulomatosis
K. Zycinska, K. Wardyn, T. Zielonka (Warsaw, Republic Of Serbia)
| |
Pulmonary involvement in polymyositis with anti-signal recognition particle autoantibody
B. Gorbatai, K. N‘Guyen, E. Torabi, J. B. Auliac (Mantes la Jolie, France)
| |
Transbronchial lung biopsy (TBLB) at King Hussein Medical Center (KHMC), analysis of 7 year results
H. El-Khushman, A. Sharara, N. Al-Qaisi, K. Al-Nadi, N. Taha, M. Hijazi (Amman, Jordan)
| |
Cystic lung disease associated with Sjögren's syndrome: 3 cases
F. S. Oymak, K. Yildiz, H. Buyukoglan, O. Canoz, M. Gulec, R. Demir, I. Gulmez (Kayseri, Turkey)
| |
Effect of azithromycin-predominant combined therapy on patients with diffuse panbronchiolitis
H. Li, Y. Zhou, F. Fan, X. Li, H. Yu (Shanghai, China)
| |
Air travel for patients with interstitial lung diseases
A. Farghaly, Y. El. Sayed, Y. A. Aziz, K. M.F. Zamzam, M. A. Tag El-Din (Cairo, Egypt)
| |
The abilities of MSCT in diagnostic of rheumatoid arthritis
E. M. Minina, V. I. Amosov, O. V. Lukina, A. A. Speranskaya, B. S. Kiaei (St.-Petersburg, Russian Federation)
| |
Pulmonary alveolar microlithiasis in two young siblings: case report
M. Kale, P. Khatavkar, M. Rahalkar, A. Rahalkar (Pune, India)
| |
Retrospective analysis of patients with diffuse parenchimal lung diseases (dpld) admitted to San Camillo-Forlanini Hospital in Rome (Italy)
M. Quartieri, G. Farinelli, G. Shmid, G. Puglisi (Rome, Italy)
| |
Idiopathic pulmonary fibrosis: efficacy of complex immunosuppressive therapy by cyclophosphamide and corticosteroids
A. P. Rebrov, E. E. Arkhangelskaya, E. Y. Ponomareva (Saratov, Russian Federation)
| |
Intercurrent intractable factors in autoimmune pulmonary alveolar proteinosis
Y. Inoue, T. Arai, M. Kitaichi, M. Akira, K. Nakata, R. Tazawa, J. Otsuka, M. Hirose, A. Matsumuro, M. Sakatani, Japanese Center of RLDC, Osaka Symposium on Respiratory Diseases (Sakai, Niigata, Japan)
| |
Lymphatic fluctuation in parenchymal remodelling stage of organising pneumonia, nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis
V. Capelozzi, C. De Araujo, C. De Carvalho, R. Kairalla, E. R. Parra (São Paulo, Brazil)
| |
Peak oxygen consumption is reduced in patients with sarcoidosis and is associated with the diffusion capacity of the lung and the left ventricular function
E. Gialafos, A. Kalianos, L. Velentza, M. Ilias, T. Vasiliki, M. Georgia, S. Sofia, A. Roula, E. Peros, C. Kostopoulos, A. Rapti (Athens, Greece)
| |
Survival and prognostic factors in progressive systemic sclerosis with lung involvement
S. F. Zuhur, B. Müsellim, G. Öngen (Istanbul, Turkey)
| |
Diagnostic mistakes in patients with idiopathic interstitial pneumonias (IIP)
I. Stepanyan., A. Ergeshov, A. Zaytseva, E. Shmelev (Moscow, Russian Federation)
| |
Surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis: a systematic review
F. Maldonado, J. Ryu, V. Montori (Rochester, United States Of America)
| |